Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02543645
Title A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celldex Therapeutics

urinary bladder cancer

head and neck cancer

triple-receptor negative breast cancer

renal cell carcinoma

lung non-small cell carcinoma



Atezolizumab + Varlilumab

Age Groups: adult
Covered Countries USA

No variant requirements are available.